A nested case-control study of the effectiveness of screening for prostate cancer: Research design

Journal of Clinical Epidemiology

Volumn 54, Issue 6, 2001, Pages 558-564

  Concato, John ^a,b   Peduzzi, Peter ^a,b   Kamina, Ayumi ^b   Horwitz, Ralph I ^a,b  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Case control study; Digital rectal examination; Mortality; Prostate cancer; Prostate specific antigen; Screening

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; AMBULATORY CARE; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CANCER SURVIVAL; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSTATE CARCINOMA; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; SAMPLE;

CASE-CONTROL STUDIES; HUMANS; MALE; MASS SCREENING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0035019849     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(00)00355-3     Document Type: Article

References (29)

1. Landis S.H., Murray T., Bolden S., Wingo P.A. Cancer statistics, 1999. CA. 49:1999;8-31.
2. Mettlin C., Jones G., Averette H., Gusberg S.B., Murphy G.P. Defining and updating the American Cancer Society guidelines for the cancer-related checkup. prostate and endometrial cancers CA. 43:1993;42-46.
3. U.S. Preventive Services Task Force. Screening for prostate cancer. Guide to clinical preventive services. Baltimore: Williams & Wilkins, 1989.
4. Mettlin C., Lee F., Drago J., Murphy G.P. The American Cancer Society National Prostate Cancer Detection Project. Cancer. 67:1991;2949-2958.
5. Gohagan J.K., Prorok P.C., Kramer B.S., Cornett J.E. Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute. J Urol. 152:1994;1905-1909.
6. Schroder F.H., Bangma C.H. The European randomized study of screening for prostate cancer. Br J Urol. 79:1997;68-71.
7. Concato J., Shah N., Horwitz R.I. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 342:2000;1887-1892.
8. Benson K., Hartz A.J. A comparison of observational studies and randomized, controlled trials. N Engl J Med. 342:2000;1878-1886.
9. Clarke E.A., Anderson T.W. Does screening of "Pap" smears help prevent cervical cancer? A case-control study. Lancet. 2:1979;1-4.
10. Macgregor E., Moss S.M., Parkin D.M., Day N.E. A case-control study of cervical cancer screening in north east Scotland. BMJ. 290:1985;1543-1546.
11. Verbeek A.L.M., Hendricks J.H.C.L., Holland R., Mravunac M., Sturmans F., Day N.E. Reduction of breast cancer mortality through mass screening with modern mammography. first results of the Nijmegen project, 1975-1981 Lancet. 1:1984;1222-1224.
12. Selby J.V., Friedman G.D., Quesenberry C.P., Weiss N.S. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 326:1992;653-657.
13. Friedman G.D., Hiatt R.A., Quesenberry C.P., Selby J.V. Case-control study of screening for prostatic cancer by digital rectal examinations. Lancet. 337:1991;1526-1529.
14. Jacobsen S.J., Bergstralh E.J., Katusic S.K., Guess H.A., Darby C.H., Silversten M.D.et al. Screening digital rectal examination and prostate cancer mortality. a population-based case-control study Urology. 52:1998;173-179.
15. Labrie F., Candas B., Dupont A., Cusan L., Gomez J.L., Subury R.E.et al. Screening decreases prostate cancer death. first analysis of the 1988 Quebec prospective randomized controlled trial Prostate. 38:1999;83-91.
16. Concato J. Prostate specific antigen. a useful screening test? Cancer J Sci Am. 6:2000;S188-S192.
17. Thompson RS, WEB, Taplin SH, Grothaus L, Immanuel V, Salazar A, et al. A population-based case-cohort evaluation of the efficacy of mammographic screening for breast cancer. Am J Epidemiol 1994;140:889-901.
18. Weiss N.S., McKnight B., Stevens N.G. Approaches to the analysis of case-control studies of the efficacy of screening for cancer. Am J Epidemiol. 135:1992;817-823.
19. Flanders W.D., Longini I.M.J. Estimating benefits of screening from observational cohort studies. Stat Med. 9:1990;969-980.
20. Concato J. What is a screening test? Misclassification bias in observational studies of screening for cancer. J Gen Intern Med. 12:1997;607-612.
21. Gill T.M., Horwitz R.I. Evaluating the efficacy of cancer screening. clinical distinctions and case-control studies J Clin Epidemiol. 48:1995;281-292.
22. Catalona W.J., Smith D.S., Ratliff T.L., Dodds K.M., Coplen D.E., Yuan J.J.et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med. 324:1991;1156-1161.
23. Fleming C., Fisheer E.S., Chang C.H., Bubolz T.A., Malenka D.J. Studying outcomes and hospital utilization in the elderly. The advantages of a merged data base for Medicare and Veterans Affairs hospitals. Med Care. 30:1992;377-391.
24. Fisher S.G., Weber L., Goldberg J., Davis F. Mortality ascertainment in the veteran population. alternatives to the National Death Index Am J Epidemiol. 141:1995;242-250.
25. Stampfer M.J., Willett W.C., Speizer F.E., Dysert D.C., Lipnick R., Rosner B.et al. Test of the National Death Index. Am J Epidemiol. 119:1984;837-839.
26. Potosky A.L., Miller B.A., Albertsen P.C., Kramer B.S. The role of increasing detection in the rising incidence of prostate cancer. JAMA. 273:1995;548-552.
27. Murphy G.P., Natarahan N., Pontes J.E., Schmitz R.L., Smart C.R., Schmidt J.D.et al. The national survey of prostate cancer in the United States by the American College of Surgeons. J Urol. 127:1982;928-933.
28. Schlesselman J.J. Case-control studies. 1982;Oxford University Press, New York.
29. Breslow N.E., Day N.E. Design considerations. Statistical methods in cancer research. 1980;International Agency for Research on Cancer, Lyon.